AbbVie secures further strong results for potential blockbuster
March 13, 2018Research and Development AbbVie, biotech, drugs, elagolix, pharma, pharmaceutical
AbbVie’s elagolix has been slated as a blockbuster-in-the-making by analysts predicting big things for the potential treatment for uterine fibroids …
FDA inspection reveals cGMP issues at Biocon’s major Malaysia facility
March 13, 2018Manufacturing and Production Biocon, CGMP, FDA, pharma
Biocon’s insulin production facility in Johar, Malaysia – the largest integrated insulin manufacturing facility in Asia – has been slapped …
Adaxis-AZ immunotherapy combo hit by clinical hold after death
March 13, 2018Manufacturing and Production, Research and Development Adaxis, AstraZeneca, Imfinzi, biotech, drugs, immunotherapy, pharma, pharmaceutical
Adaxis and AstraZeneca announced that they had agreed a combination program for axalimogene filolisbac and Imfinzi, respectively, back in 2014 …
Anthera pulls the plug on Sollpura after Phase 3 failure, shares plummet 84%
March 13, 2018Manufacturing and Production, Research and Development Anthera, Eli Lilly, Sollpura, pharma, trial failure
Anthera Pharmaceuticals has announced that it is to terminate development of its investigational pancreatic enzyme replacement therapy (PERT) Sollpura after …
Novartis reshuffle begins under new CEO
March 13, 2018Manufacturing and Production, Medical Communications Novartis, biotech, digital, drugs, pharma, pharmaceutical
It’s a common strategy that newly appointed CEOs will try to change the direction of the company via rejigging leadership …
Pfizer begins sell-off, shedding CNS drug to Biogen for $590m
March 13, 2018Manufacturing and Production, Sales and Marketing Biogen, CNS, Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer’s decision to back out of the neuroscience space was a strategic move that send shudders through the entire industry, …
Drug safety: EudraVigilance and an evolving system
March 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, pharma, pharmacovigilance
The importance of drug safety is back in the news due to sodium valproate and Ben Hargreaves examines how the …
AstraZeneca’s Brilinta proves safety in heart attack patients at Phase 3
March 12, 2018Research and Development, Sales and Marketing AstraZeneca, Brilinta, heart attack
AstraZeneca has revealed new Phase 3 data on its direct-acting P2Y12 receptor antagonist Brilinta (ticagrelor) at the American College of …
Impax agrees to $35 million settlement over anticompetitive practices with Valeant generic
March 12, 2018Sales and Marketing Impax, Medicis, Solodyn, Valeant, generic, pharma
Impax Pharmaceuticals has acquiesced to paying a $35 million settlement in order to resolve part of an antitrust lawsuit it …
Martin Shkreli sentenced to seven years in jail for securities fraud
March 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Martin Shkreli, pharma
Three years after he became “the most hated man in America” overnight for jacking up the price of life-saving HIV-related …
Sanofi and Regeneron reveal strong data and a price drop for Praluent
March 12, 2018Research and Development, Sales and Marketing Regeneron, Sanofi, pharma, praluent
Sanofi and Regeneron have revealed strong new data for its PCSK9 inhibitor Praluent showing the first-ever reduction in deaths within …
Hikma’s Advair generic delayed in the US
March 12, 2018Sales and Marketing Advair, FDA, GSK, GlaxoSmithKline, pharma
Hikma Pharmaceuticals has been knocked back with the news that the FDA has delayed approval of its generic lung treatment …
Top Ten most popular articles on Pharmafile.com this week
March 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Biogen, Celgene, EMA, Gilead, HIV, Herceptin, Japan, NHS, Ontruzant, Sanofi, opioid crisis, opioids, pharma, real world data, top ten, zinbryta
After a particularly jarring bout of cold weather and snow, we may just have seen off the worst of winter …
GSK loses £37m appeal over pay-to-delay tactics to block Seroxat competition
March 9, 2018Medical Communications, Sales and Marketing GSK, Pay to delay, Seroxat, antidepressant, pay-to-delay, pharma
GlaxoSmithKline has suffered a sizeable blow after losing an appeal disputing that it had engaged in anti-competitive pay-to-delay tactics to …
Convert secures €13.6m grant to develop targeted chemo for oxygen-deprived tumours
March 9, 2018Medical Communications, Research and Development Belgium, Cancer, Convert pharma, chemotherapy, pharma
Belgium’s Convert Pharmaceuticals has secured a €13.6 million grant for initial development efforts on a new targeted chemotherapy drug which …
Appeal could throw spanner in the works for Regeneron’s Irish expansion
March 9, 2018Manufacturing and Production, Medical Communications Ireland, Regeneron, pharma
Regeneron is facing a single man-sized obstacle in plans to expand operations at its campus in Limerick, Ireland with a …
VBL Therapeutics’ shares plummet on Phase 3 glioblastoma failure
March 9, 2018Medical Communications, Research and Development VBL, VBL Therapeutics, glioblastoma, pharma, trial failure
Israeli drug development firm VBL Therapeutics has been left reeling after it announced that its lead oncology product ofranergene obadenovec, …
Opioids are no more effective than common painkillers, study reveals
March 8, 2018Medical Communications, Research and Development US, opioid crisis, opioids, pharma
A team of researchers at the Minneapolis Veterans Affairs Health Care System has found that, for all their risks, opioids …
Ontruzant launches to become first Herceptin biosimilar available in the UK
March 8, 2018Sales and Marketing Cancer, Herceptin, MSD, Ontruzant, Roche, Samsung Bioepis, pharma
Ontruzant, the biosimilar version of Herceptin (trastuzumab ) originally developed by Korean firm Samsung Bioepis, has launched for patients in …
EvoTec to command vast Sanofi resources in infectious disease R&D partnership
March 8, 2018Research and Development, Sales and Marketing Evotec, Sanofi, infectious disease, infective disease, pharma
Sanofi has announced it is to team up with biotech drug discovery specialist EvoTec to leverage a new open innovation …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
